Progressive improvement in short-, medium- and long-term graft survival in kidney transplantation patients in Ireland - a retrospective study

被引:12
作者
Sexton, Donal J. [1 ]
O'Kelly, Patrick [1 ]
Williams, Yvonne [1 ,2 ]
Plant, William D. [3 ]
Keogan, Marie [4 ]
Khalib, Khairin [4 ]
Doyle, Brendan [5 ]
Dorman, Anthony [5 ]
Suesal, Caner [6 ]
Unterrainer, Christian [6 ]
Forde, James [2 ]
Power, Richard [2 ]
Smith, Gordon [2 ]
Mohan, Ponnusamy [2 ]
Denton, Mark [1 ]
Magee, Colm [1 ]
de Freitas, Declan G. [1 ]
Little, Dilly [2 ]
O'Seaghdha, Conall M. [1 ]
Conlon, Peter J. [1 ,7 ]
机构
[1] Beaumont Hosp, Dept Nephrol & Kidney Transplantat, Natl Kidney Transplant Serv, Dublin, Ireland
[2] Beaumont Hosp, Dept Transplant Urol, Dublin, Ireland
[3] Univ Coll Cork, Cork Univ Hosp, Hlth Serv Execut Ireland, Natl Renal Off, Cork, Ireland
[4] Beaumont Hosp, Dept Immunol, Dublin, Ireland
[5] Beaumont Hosp, Dept Pathol, Dublin, Ireland
[6] Heidelberg Univ, Inst Immunol, Collaborat Transplant Study, Heidelberg, Germany
[7] Royal Coll Surgeons Ireland, Dublin, Ireland
关键词
kidney transplant; long-term; outcomes; RENAL-ALLOGRAFT SURVIVAL; PLUS MYCOPHENOLATE-MOFETIL; RANDOMIZED-TRIAL; UNITED-STATES; TACROLIMUS; AZATHIOPRINE; RECIPIENTS; EFFICACY; OUTCOMES; SAFETY;
D O I
10.1111/tri.13470
中图分类号
R61 [外科手术学];
学科分类号
摘要
It is often quoted that while short-term graft survival in kidney transplantation has improved in recent years, it has not translated into a commensurate improvement in long-term graft survival. We considered whether this was true of the entire experience of the national kidney transplant program in Ireland. A retrospective analysis of the National Kidney Transplant Service (NKTS) database was undertaken to investigate patient and graft survival for all adult first deceased donor kidney transplant recipients in Ireland, 1971-2015. Three thousand two hundred and sixty recipients were included in this study. Kaplan-Meier methods were used to estimate survival at each time period post transplant for the various eras of transplantation. Uncensored graft survival has improved over the course of the program in Ireland at various time points despite risk factors for graft failure progressively increasing over successive eras. For example the graft survival at 15 years post transplant has increased from 10% in 1971-1975 to 45% by 1996-2000. Ireland has experienced a progressive improvement in long-term graft survival following kidney transplantation. Whether these trends are attributable to biological or nonbiological factors is unclear but likely involves a combination of both.
引用
收藏
页码:974 / 984
页数:11
相关论文
共 43 条
  • [11] GASTON RS, 2017, AM J TRANSPLANT, DOI DOI 10.1038/CMI.2013.21
  • [12] Kidney Graft Survival in Europe and the United States: Strikingly Different Long-Term Outcomes
    Gondos, Adam
    Doehler, Bernd
    Brenner, Hermann
    Opelz, Gerhard
    [J]. TRANSPLANTATION, 2013, 95 (02) : 267 - 274
  • [13] Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine plus mycophenolate mofetill after cadaveric kidney transplantation: Results at three years.
    Gonwa, T
    Johnson, C
    Ahsan, N
    Alfrey, EJ
    Halloran, P
    Stegall, M
    Hardy, M
    Metzger, R
    Shield, C
    Rocher, L
    Scandling, J
    Sorensen, J
    Mulloy, L
    Light, J
    Corwin, C
    Danovitch, G
    Wachs, M
    VanVeldhuisen, P
    Leonhardt, M
    Fitzsimmons, WE
    [J]. TRANSPLANTATION, 2003, 75 (12) : 2048 - 2053
  • [14] The financial impact of immunosuppressant expenses on new kidney transplant recipients
    Gordon, Elisa J.
    Prohaska, Thomas R.
    Sehgal, Ashwini R.
    [J]. CLINICAL TRANSPLANTATION, 2008, 22 (06) : 738 - 748
  • [15] Disparities in Kidney Transplant Outcomes: A Review
    Gordon, Elisa J.
    Ladner, Daniela P.
    Caicedo, Juan Carlos
    Franklin, John
    [J]. SEMINARS IN NEPHROLOGY, 2010, 30 (01) : 81 - 89
  • [16] Mycophenolate mofetil in renal allograft recipients - A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection
    Halloran, P
    Mathew, T
    Tomlanovich, S
    Groth, C
    Hooftman, L
    Barker, C
    [J]. TRANSPLANTATION, 1997, 63 (01) : 39 - 47
  • [17] Molecular assessment of disease states in kidney transplant biopsy samples
    Halloran, Philip F.
    Famulski, Konrad S.
    Reeve, Jeff
    [J]. NATURE REVIEWS NEPHROLOGY, 2016, 12 (09) : 534 - 548
  • [18] OPTN/SRTR 2016 Annual Data Report: Kidney
    Hart, A.
    Smith, J. M.
    Skeans, M. A.
    Gustafson, S. K.
    Wilk, A. R.
    Robinson, A.
    Wainright, J. L.
    Haynes, C. R.
    Snyder, J. J.
    Kasiske, B. L.
    Israni, A. K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 18 - 113
  • [19] HOENGER G, 2017, TRANSPLANT DIRECT, V3, DOI DOI 10.1097/TXD.0000000000000654
  • [20] James Alexandra, 2015, Curr Transplant Rep, V2, P113